NovoCure Limited (NVCR)
(Real Time Quote from BATS)
$16.61 USD
+0.18 (1.10%)
Updated Sep 25, 2024 11:14 AM ET
3-Hold of 5 3
D Value C Growth B Momentum C VGM
12 month EPS
NVCR 16.61 +0.18(1.10%)
Will NVCR be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for NVCR based on the 1-3 month trading system that more than doubles the S&P 500.
About 12 Month EPS
The Price and 12 Month EPS chart displays the company's stock price along with the trailing twelve month (TTM) EPS. A company's earnings per share, or EPS, is a key financial metric on its income statement that investors and analysts use to assess its performance and stock price. EPS is the net income, or profit, a company generates during a period for each share of common stock it has outstanding.